financetom
Business
financetom
/
Business
/
Max Life backs out of IDBI Federal stake sale making AB Birla Sun Life sole bidder
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Max Life backs out of IDBI Federal stake sale making AB Birla Sun Life sole bidder
Jun 8, 2018 11:11 AM

After IDBI Bank and Federal Bank put fresh conditions, Max Life Insurance on Friday walked out of IDBI Federal Life Insurance stake sale, making Aditya Birla Sun Life Insurance as the sole bidder.

Analjit Singh promoted, Max Financial Services, on Friday said that Max Life Insurance has decided not to pursue the current acquisition opportunity and no longer considering any of the fund raising proposals.

IDBI Federal Life is a joint venture between IDBI Bank and Federal Bank, with Belgium-based Ageas SA/NV as the foreign partner. While IDBI Bank holds a 48% stake in the venture, Federal Bank and Belgian life insurer Ageas hold 26% each.

Earlier, Max Group had given IDBI Bank and Federal Bank time till today evening to accept its conditions.

The Max Group’s conditions include exclusivity of bancassurance tie-up and productivity guarantee from IDBI-Federal even after the merger, if any; auto renewal of bancassurance deal after 5 years if productivity milestones are delivered and indemnification if bancassurance tie-up jeopardized by change in control at IDBI Bank.

Yesterday, Analjit Singh, founder and Chairman, Max Group, told CNBC-TV18 that bidding for IDBI Federal Life Insurance without assurance is not making any sense.

Singh said Max Life Insurance had made aggressive bids for IDBI Federal Life Insurance. But the prerequisites we had asked, like performance guarantees etc, are unlikely to be given by IDBI Bank and Federal Bank.

IDBI Federal Life Insurance had seen interest from nine companies including Kotak Life, Max Life Insurance and Exide Life Insurance.

First Published:Jun 8, 2018 8:11 PM IST

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Centessa Pharmaceuticals Shares Up After Drug Trial Found to Restore Wakefulness in Subjects
Centessa Pharmaceuticals Shares Up After Drug Trial Found to Restore Wakefulness in Subjects
Sep 11, 2024
01:03 PM EDT, 09/10/2024 (MT Newswires) -- Centessa Pharmaceuticals ( CNTA ) shares were up nearly 4% in recent Tuesday trading after the company said ORX750 was found to restore wakefulness in acutely sleep-deprived healthy volunteers. Interim results from an ongoing phase 1 trial of the company's experimental medicine found that the higher dose of the drug restored normative wakefulness...
Employee of French drugmaker Ipsen to plead guilty to US insider trading
Employee of French drugmaker Ipsen to plead guilty to US insider trading
Sep 11, 2024
BOSTON, Sept 10 (Reuters) - An employee of French drugmaker Ipsen has agreed to plead guilty to illegally making more than $262,000 by trading on inside information he learned about his company's plans to acquire cancer drug developer Epizyme in 2022. Dishant Gupta, Ipsen's director of data strategy and operations, plans to plead guilty to securities fraud and is settling...
Why Is Ally Financial Stock Falling On Tuesday?
Why Is Ally Financial Stock Falling On Tuesday?
Sep 11, 2024
Ally Financial Inc. ( ALLY ) shares are trading lower on Tuesday after the company’s CFO reportedly noted intensifying credit challenges among borrowers at a conference. The firm’s CFO, Russell Hutchinson, revealed that the company’s credit troubles have deepened this quarter, with borrowers grappling more than ever with soaring inflation and living costs, reported Reuters. Delinquencies in the company’s retail...
Oracle May Need 'Aggressive' Second-Half Ramp to Meet Full-Year Revenue Guidance, BofA Says
Oracle May Need 'Aggressive' Second-Half Ramp to Meet Full-Year Revenue Guidance, BofA Says
Sep 11, 2024
01:10 PM EDT, 09/10/2024 (MT Newswires) -- Oracle (ORCL) continued to benefit from cloud momentum in the fiscal first quarter but an aggressive ramp in the second half may be required to achieve management's full-year revenue guidance following a below-expected top-line guide for the second quarter, BofA Securities said. The brokerage raised its price target on the stock to $175...
Copyright 2023-2026 - www.financetom.com All Rights Reserved